map.1rbw.org
Open in
urlscan Pro
104.207.254.35
Public Scan
Submitted URL: https://1rbw.org/
Effective URL: https://map.1rbw.org/
Submission: On June 17 via api from US — Scanned from DE
Effective URL: https://map.1rbw.org/
Submission: On June 17 via api from US — Scanned from DE
Form analysis
0 forms found in the DOMText Content
ONE RETINOBLASTOMA WORLD Retinoblastoma is an aggressive eye cancer that affects 8,000 new babies and children worldwide each year. Early detection and coordinated, evidence-based care at expert treatment centers are key to saving lives and vision. FIND A TREATMENT CENTER NEAR YOU i OR GO DIRECTLY TO THE MAP i Please be patient while the map loads (100%) ... ONE RETINOBLASTOMA WORLD Map is currently undergoing updates to be launched in the first quarter of 2024. Early detection of retinoblastoma and coordinated, evidence-based care at expert treatment centers are key to saving lives and vision. Learn more » FIND A LOCATION i Esri, Garmin, NGA, USGS | Earthstar Geographics | Esri, FAO, NOAA | Esri | Zoomen auf 0 200 400km MAP LEGENDABOUT THIS MAP » RETINOBLASTOMA PREVALENCE* 1-50 patients 51-100 patients 101-500 patients 501-1,000 patients 1,001-1,500 patients 1,501+ patients * based on incidence of 1 in 16,000 live births1 Source 1Kivela, T. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol 93, 1129-31 (2009) WORLD BANK INCOME LEVEL** low income middle income ** high income countries have no pattern RETINOBLASTOMA TREATMENT CENTERS GENETIC TESTING LABS STORIES FACILITIES $0 $0 $0 COUNTRY INFORMATION -- region -- Africa Americas Asia Europe Oceania -- country --AfghanistanAlandAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBosnia and HerzegovinaBotswanaBrazilBritish Indian Ocean TerritoryBritish Virgin IslandsBruneiBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCape VerdeCayman IslandsCentral African RepublicChadChileChinaClipperton IslandColombiaComorosCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzech RepublicDemocratic Republic of the CongoDenmarkDjiboutiDominicaDominican RepublicEast TimorEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaFalkland IslandsFaroe IslandsFederated States of MicronesiaFijiFinlandFranceFrench PolynesiaFrench Southern and Antarctic LandsGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuamGuatemalaGuernseyGuineaGuinea BissauGuyanaHaitiHeard Island and McDonald IslandsHondurasHong Kong S.A.R.HungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyIvory CoastJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKosovoKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacao S.A.RMacedoniaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMauritaniaMauritiusMexicoMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth KoreaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestinePanamaPapua New GuineaParaguayPeruPhilippinesPitcairn IslandsPolandPortugalPuerto RicoQatarRepublic of CongoRepublic of SerbiaRomaniaRussiaRwandaSaint BarthelemySaint HelenaSaint Kitts and NevisSaint LuciaSaint MartinSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and South Sandwich IslandsSouth KoreaSouth SudanSpainSri LankaSudanSurinameSwazilandSwedenSwitzerlandSyriaTaiwanTajikistanThailandThe BahamasTogoTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos IslandsTuvaluUgandaUkraineUnited Arab EmiratesUnited KingdomUnited Republic of TanzaniaUnited States Minor Outlying IslandsUnited States Virgin IslandsUnited States of AmericaUruguayUzbekistanVanuatuVaticanVenezuelaVietnamWallis and FutunaWestern SaharaYemenZambiaZimbabwe Explore information about different countries by using the menus above. TREATMENT CENTER INFORMATION -- country --AfghanistanArgentinaAustraliaAustriaBelgiumBotswanaBrazilBurundiCanadaChileChinaColombiaCosta RicaCubaCzech RepublicDemocratic Republic of the CongoDenmarkEgyptEstoniaEthiopiaFinlandFranceGambiaGermanyGhanaGuatemalaHondurasHong Kong S.A.R.HungaryIndiaIndonesiaIranIrelandIsraelItalyIvory CoastJapanJordanKenyaLebanonMalawiMalaysiaMaliMexicoMoroccoMyanmarNepalNetherlandsNew ZealandNicaraguaNigeriaPakistanPalestinePeruPhilippinesPolandPortugalRepublic of SerbiaRussiaRwandaSaudi ArabiaSingaporeSlovakiaSouth AfricaSouth KoreaSpainSwedenSwitzerlandThailandTurkeyUgandaUkraineUnited KingdomUnited Republic of TanzaniaUnited States of AmericaVenezuelaVietnamYemenZambia Explore information about retinoblastoma treatment centers in a particular location by using the menus above. WORLDWIDE DISTRIBUTION PREVALENCE BY WORLD BANK LEVEL Low income Middle income High income CENTERS BY WORLD BANK LEVEL Low income Middle income High income ADVANCED MAP FILTERS Show only retinoblastoma treatment centers that offer the following treatment types: EXAMINATION UNDER ANAESTHESIA IMAGING ENUCLEATION FOCAL THERAPY CHEMOTHERAPY RADIOTHERAPY RADIOLOGY GENETIC TESTING AVAILABLE DEMOGRAPHICS Explore health related variables by using the global map layers below. To remove demographic information and return to the map view showing retinoblastoma prevalence, uncheck any checked boxes below. GLOBAL DEMOGRAPHICS Adjust Color Intensity Show all countries on map » Human Development Index Poverty Headcount Maternal Mortality Ratio Births Attended by Skilled Health Personnel Antenatal Care Coverage Cancer Control Policy Physician Density CONTRIBUTE DATA TO THIS MAP If you have information you would like to submit about a treatment center, a genetic testing laboratory, or a story not currently represented on this map, please contact us by clicking on the link below. Contact Us CONTACT US HOW TO DONATE HELP US ACHIEVE EQUAL AND OPTIMAL CARE FOR ALL CHILDREN WITH RETINOBLASTOMA Website operating costs are funded by private donors. Your tax-deductible donation will help us sustain the One Retinoblastoma World Map. The One Retinoblastoma World Map was created by Dr. Helen Dimaras (Director of Global Eye Health Research, The Hospital for Sick Children). Donations from Canada can be made online to the SickKids Foundation by clicking the button below, or by calling +1-416-813-6166. Donations from outside of Canada can be coordinated by calling +1-416-813-1211. When processing donations please specify that funds are for Dr. Helen Dimaras' One Retinoblastoma World Map. Donate Now « Close ABOUT RETINOBLASTOMA WHAT IS RETINOBLASTOMA? Retinoblastoma is an aggressive eye cancer that develops in early infancy and childhood. HOW COMMON IS RETINOBLASTOMA? The incidence of retinoblastoma is constant worldwide at one case per 16,000 – 18,000 live births. This corresponds to about 8,000 new cases every year. HOW IS RETINOBLASTOMA DETECTED? Often the first sign of retinoblastoma is a white pupil, similar to a cat's eye (also called "leukocoria"). The white pupil is often seen on flash photography or under dim lighting, when the pupil dilates naturally. Other signs of retinoblastoma may include an inward- or outward-turning eye (strabismus), or a swollen, bulging eye (proptosis). Urgent referral to an eye doctor is recommended for a child exhibiting these signs. HOW IS RETINOBLASTOMA TREATED? Retinoblastoma treatment is multidisciplinary, requiring management by a dedicated team with expertise in eyes, cancer, genetics, and nursing, among others. Treatment depends on the severity of disease at diagnosis, and may involve the use of several different techniques and methods. Guidelines for treatment of retinoblastoma have been published in Canada and Kenya. Guidelines for the management of retinoblastoma in countries with limited resources have also been developed. IS RETINOBLASTOMA CURABLE? Retinoblastoma can be cured if diagnosed early and the cancer is confined within the eye. However, potentially effective therapies are not accessed in many countries, because of poor retinoblastoma awareness, unaffordable costs (e.g., medicine or transport and accommodation), and lack of health care coordination. As a result, survival rates vary from country to country. ABOUT ONE RETINOBLASTOMA WORLD WHAT IS ONE RETINOBLASTOMA WORLD? One Retinoblastoma World is a global network with the bold idea that all children with retinoblastoma can have equal opportunity to optimal retinoblastoma care. Through global collaboration and research, we will foster optimal, coordinated, evidence-based retinoblastoma care. We aim to make retinoblastoma a zero-death disease. HOW CAN I SUPPORT THE ONE RETINOBLASTOMA WORLD MAP? We welcome all feedback about the One Retinoblastoma World Map, including information about missing retinoblastoma treatment centers and genetic testing labs. To contribute information to the map, please see the section below called, "How do I add information to this map?" Help Us Achieve Equal and Optimal Care for all Children with Retinoblastoma: Donate Now Website operating costs are funded by private donors. Your tax-deductible donation will help us sustain the One Retinoblastoma World Map. The One Retinoblastoma World Map was created by Dr. Helen Dimaras (Director of Global Eye Health Research, The Hospital for Sick Children). Donations from Canada can be made online to the SickKids Foundation or by calling +1-416-813-6166. Donations from outside of Canada can be coordinated by calling +1-416-813-1211. When processing donations please specify that funds are for Dr. Helen Dimaras' One Retinoblastoma World Map. ABOUT THIS MAP WHAT IS THE PURPOSE OF THIS MAP? This map is a key initiative of One Retinoblastoma World. It aims to connect affected families to expert care; promote evidence-based retinoblastoma treatment; and facilitate enhanced collaboration among treatment centers. 1) CONNECT TO EXPERT CARE Prompt referral and access to expert treatment is key for retinoblastoma survival. Visitors to the site can enter their coordinates and be directed to the nearest expert retinoblastoma treatment center. 2) EVIDENCE-BASED TREATMENT Listing retinoblastoma capacity in a standard and transparent manner aims to promote adherence and adoption of a common standard of care. The data collected for each retinoblastoma treatment center and genetic testing labs represent the multidisciplinary resources and expertise recommended for optimal retinoblastoma care. 3) ENHANCED COLLABORATION The map connects global caregivers to one another, sharing everything from basic contact details to available resources and personnel in individual treatment centers and genetic testing labs. This will facilitate referral of patients between sites, enhance knowledge exchange and potentially increase research capacity. HOW DO I NAVIGATE THIS MAP? Here are some quick tips for navigating the map. Note that you must have the map in "focus" in order for these to work (if not in focus, clicking anywhere on the map will bring it into focus.) USING THE MOUSE Click and drag the mouse to pan, use mouse scroll wheel to zoom in and out, and double click to zoom in. Hold the SHIFT key while dragging the mouse to zoom in to a selection, or hold the SHIFT key while clicking to center the map around that point. USING THE KEYBOARD Use the arrow keys to pan, use the plus key (+) to zoom in, and use the minus key (-) to zoom out. ABOUT THE DATA HOW IS THE TREATMENT CENTER DATA COLLECTED? Using publicly available information, we identify and contact retinoblastoma specialists from around the world. The specialists are invited to answer questions about their treatment center or genetic testing lab and then this information is uploaded onto the map. Data are self-reported by specialists and have not been audited by the One Retinoblastoma World map team. Each year, participating retinoblastoma treatment centers and genetic testing labs are invited to update their information, to ensure that the One Retinoblastoma World map is current. HOW ARE THE RETINOBLASTOMA ESTIMATES FOR EACH COUNTRY DETERMINED? The expected number of patients newly diagnosed with retinoblastoma annually per country is calculated by multiplying the global retinoblastoma incidence (1 in 16,000 live births per year1) by the forecast number of surviving infants (country population2 x (birth rate3/1000) x [1 - (infant mortality rate4/1000)]). Sources 1Kivela, T. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol 93, 1129-31 (2009) 2Indicator: Population, total. 2015. World Bank 3Indicator: Birth rate, crude (per 1000 people) 2015. World Bank 4Indicator: Mortality rate, infant (per 1000 births). 2015. World Bank HOW DO I ADD INFORMATION TO THIS MAP? If you have information you would like to submit about a treatment center, a genetic testing laboratory, or a story not currently represented on this map, please contact us. WHERE DO I FIND A LIST OF RETINOBLASTOMA TREATMENT CENTERS? We have a list of retinoblastoma treatment centers separate from this map where you can view the centers by country. Partners: How to Donate Help Us Achieve Equal and Optimal Care for all Children with Retinoblastoma